Same Medicine, Smarter Choice
Understanding customer awareness, trust, and adoption of branded substitutes through customer data & survey-led insights.
How Indians Can Save Up To 60% On Their Medicine Costs
Rising healthcare costs are becoming a real strain on Indian households. For most families, medicines make up the largest share of out-of-pocket medical spending, especially for chronic conditions that require long-term treatment.
What many people don’t realise is that they often end up paying almost twice as much for the same treatment, simply because of the brand name on the strip.
This is where branded substitutes, also known as branded generics, come in.
They are manufactured and marketed by well-known brands, contain the same active ingredients, meet the same quality and safety standards, and provide the same clinical benefits as the other branded medicines with the same composition, but at a significantly lower cost. Choosing them is not about compromise. It’s about making a smarter, more informed decision.
This report brings together insights from real users, doctors, and PharmEasy data to break common myths around branded substitutes, highlight the real and visible savings they offer, and show how they are reshaping medicine-buying behaviour in India.
What PharmEasy User and Survey Data Reveal
The shift toward branded substitutes is not theoretical. It’s already happening at scale.
Key findings from PharmEasy data show:
- Savings of up to 60% reported by users who switched to branded substitutes, significantly reducing their overall medicine spend.
- Adoption nearly doubled, rising from 22% in 2024 to 40% in 2025.
- Our data shows that medicines for diabetes, blood pressure, and antibiotics are the categories with the highest rate of substitution.
Key findings from the user survey:
- 86% of users confirmed visible savings on their medicine bills after switching.
- Nearly 9 in 10 users (89%) said they would recommend branded substitutes to friends and family.
- Zero users reported branded substitutes to be less effective than branded medicines.
- 71% of users have been using branded substitutes for over a year, showing sustained adoption rather than short-term trials.
Lower prices also lead to something more important than savings: better treatment continuity. When medicines are affordable, people are less likely to skip doses or delay refills, which is critical for chronic and long-term conditions.